Literature DB >> 25606290

Onychomycosis nailed.

M Leelavathi1, Mn Noorlaily2.   

Abstract

Fungal infection of the nail is a common condition that causes much concern because of its disfiguring appearance. Although specific treatment is available for this condition, treatment outcome is variable and persistent nail dystrophy post-treatment may cause distress to both the patient and the physician. This article describes the current available treatment options for onychomycosis, management approach and the expected treatment outcome to enhance primary care physicians' confidence in managing this condition. Oral antifungal agents such as terbinafine and itraconazole are good treatment options for onychomycosis. Combination therapy using oral antifungal agents with topical lacquer preparations may provide added benefits. Evaluation of patient's expectations, providing information on treatment outcome, clinical cure and recurrence rates are essential in the management of onychomycosis. This article is intended to guide primary care physicians to achieve realistic treatment goals and for a satisfactory experience in the overall management of this challenging condition.

Entities:  

Keywords:  antifungal agents; itraconazole; onychomycosis

Year:  2014        PMID: 25606290      PMCID: PMC4265967     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  29 in total

1.  Fungal nail infection: assessing the new treatment options.

Authors:  Georgeanne Botek
Journal:  Cleve Clin J Med       Date:  2003-02       Impact factor: 2.321

2.  [Causative agents of onychomycosis--a retrospective study].

Authors:  Claudia Mügge; Uwe-Frithjof Haustein; Pietro Nenoff
Journal:  J Dtsch Dermatol Ges       Date:  2006-03       Impact factor: 5.584

Review 3.  Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment.

Authors:  Aditya K Gupta; Chris Drummond-Main; Elizabeth A Cooper; William Brintnell; Bianca Maria Piraccini; Antonella Tosti
Journal:  J Am Acad Dermatol       Date:  2011-08-04       Impact factor: 11.527

4.  A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.

Authors:  R Baran; M Feuilhade; P Combernale; A Datry; S Goettmann; P Pietrini; C Viguie; G Badillet; C Larnier; J Czernielewski
Journal:  Br J Dermatol       Date:  2000-06       Impact factor: 9.302

5.  Hepatic safety of itraconazole.

Authors:  Aditya K Gupta; Elisabeth Chwetzoff; James Del Rosso; Robert Baran
Journal:  J Cutan Med Surg       Date:  2002-04-15       Impact factor: 2.092

6.  Patients at risk of onychomycosis--risk factor identification and active prevention.

Authors:  A Tosti; R Hay; R Arenas-Guzmán
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

Review 7.  How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.

Authors:  E Epstein
Journal:  Arch Dermatol       Date:  1998-12

8.  [Resistance to azolic compounds in clinical Trichophyton spp. strains].

Authors:  Luis Javier Méndez-Tovar; Patricia Manzano-Gayosso; Verónica Velásquez-Hernández; Blanca Millan-Chiu; Francisca Hernández-Hernández; Rafael Mondragón-González; Rubén López-Martínez
Journal:  Rev Iberoam Micol       Date:  2007-12-31       Impact factor: 1.044

Review 9.  Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.

Authors:  Aditya K Gupta; Lindsay E Lynch
Journal:  Cutis       Date:  2004-07

Review 10.  Review of antifungal therapy and the severity index for assessing onychomycosis: part I.

Authors:  Robert Baran; Rod J Hay; Javier I Garduno
Journal:  J Dermatolog Treat       Date:  2008       Impact factor: 3.359

View more
  5 in total

1.  Causative Agents of Onychomycosis: A 7-Year Study.

Authors:  Mostafa Chadeganipour; Rasoul Mohammadi
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

2.  Aspergillus species: An emerging pathogen in onychomycosis among diabetics.

Authors:  T M Wijesuriya; J Kottahachchi; T D C P Gunasekara; U Bulugahapitiya; K N P Ranasinghe; S S Neluka Fernando; M M Weerasekara
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

Review 3.  Novel Drug Delivery Strategies for the Treatment of Onychomycosis.

Authors:  Rupinder K Dhamoon; Harvinder Popli; Madhu Gupta
Journal:  Pharm Nanotechnol       Date:  2019

Review 4.  Transmission of Onychomycosis and Dermatophytosis between Household Members: A Scoping Review.

Authors:  Aria Jazdarehee; Leilynaz Malekafzali; Jason Lee; Richard Lewis; Ilya Mukovozov
Journal:  J Fungi (Basel)       Date:  2022-01-06

5.  Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis.

Authors:  Félix Marcos-Tejedor; Natividad Santos-Carnicero; Raquel Mayordomo
Journal:  Int J Environ Res Public Health       Date:  2021-12-19       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.